Study on cannabis chemical as a treatment for pancreatic cancer may have ‘major impact,’ Harvard researcher says
Pancreatic cancer makes up just 3 percent of all cancers in America. But with a one-year survival rate of just 20 percent (and five-year survival rate of less than 8), it’s predicted to be the second leading cause of cancer-related death by 2020.
Headlines about the illness, as a result, tend to be discouraging. But this month scientists from Harvard University’s Dana-Farber Cancer Institute have released some much-needed good news. In their study, published in the journal Frontiers of Oncology on July 23, the researchers revealed that a chemical found in cannabis has demonstrated “significant therapy potential” in treatment of pancreatic cancer.
Stories you may be interested in
New approach to medical marijuana coming ‘very soon,’ DeSantis says
TALLAHASSEE — With one of his chief advisers tweeting the hashtag “NoSmokeIsAJoke,” Gov. Ron DeSantis said Monday he will “very soon” announce changes in how the state is carrying out a constitutional amendment that broadly legalized medical marijuana. Read the full story here.
Read More 
States with medical marijuana laws saw 20 percent drop in some opioid prescriptions
States with active medical marijuana laws saw certain opioid prescription rates drop nearly 20 percent compared to states without medical marijuana programs, according to a first-of-its-kind study out of Columbia University’s Irving Medical Center. Authors said the findings underscore the importance of providing patients with pain management alternatives, such as cannabis, in efforts to reduce…
Read More 
Systematic review: Efficacy and safety of medical marijuana in selected neurologic disorders
Report of the Guideline Development Subcommittee of the American Academy of Neurology: We performed a systematic review of medical marijuana (1948–November 2013) to address treatment of symptoms of multiple sclerosis (MS), epilepsy, and movement disorders. We graded the studies according to the American Academy of Neurology classification scheme for therapeutic articles. Read the full…
Read More 
Medical Cannabis and Breast Cancer
October is breast cancer awareness month and we at Arfinn Med would like to reiterate the importance of early screening and regular tests. According to the American Cancer Society: “Breast cancer is the most common cancer in American women, except for skin cancers. Currently, the average risk of a woman in the United States developing breast…
Read More 
Arfinn Med March Updates
We are very happy to announce the release of several new functions within the Arfinn Med Platform. Those include: * Text message updates from patients regarding their treatments * Templating for exam notes * Updated analytics and dosing reports * Google calendar and Calendly integrations to schedule appointments. Please view the video below for more…
Read More 
Senate bill could legalize medical marijuana in North Carolina
GREENVILLE, N.C. (WNCT) — Medical marijuana is legal in 36 states. Now, the state General Assembly could make North Carolina the latest state to open up the market to cannabis. Medical cannabis advocates are trying to throw veterans a lifeline with Senate Bill 711. “The veteran suicide rate is twice the national average in North Carolina,…
Read More